Skip to main content
. Author manuscript; available in PMC: 2023 Oct 4.
Published in final edited form as: Cell Metab. 2022 Oct 4;34(10):1442–1456.e7. doi: 10.1016/j.cmet.2022.08.018

Figure 2. Participants with cardiometabolic risk factors at baseline.

Figure 2.

All values were taken in a fasted state. Elevated risk: Low-Density Lipoprotein Cholesterol (LDL-C) ≥ 130 mg/dL, BMI ≥ 30 mg/dL, C-Reactive Protein (CRP) ≥ 2.0 mg/dL, SBP ≥ 130 mmHg, Glucose ≥ 100 mg/dL, Triglycerides (TG) ≥ 150 mg/dL, Diastolic Blood Pressure (DBP) ≥ 85 mmHg, Glycated Hemoglobin (HbA1c) ≥ 5.7 %, High-Density Lipoprotein Cholesterol (HDL-C) <40 mg/dL for males, <50 mg/dL for females. Mild Risk: LDL ≥ 100 mg/dL, BMI ≥ 25 mg/dL, SBP ≥ 120 mmHg, DBP ≥ 80 mmHg. Risk factors included elevated risks as described, but not mild risks. Reported for n=137 who completed the study. Also, see Table 3.